Tokyo Tape
Sign in
← Ono Pharmaceutical

Annual report

4528.TEDINET S100TMQ7
Period2023-04-01 → 2024-03-31
Filed2024-06-21
StandardIFRS
ConsolidatedYes
Data checks21 of 21 passed
Key figures · 157
MetricValuePeriodScopeSource row
Revenue¥502.7bn2023-04-01 → 2024-03-31Cons.Revenue IFRS
Revenue¥447.2bn2022-04-01 → 2023-03-31Cons.Revenue IFRS
Revenue¥361.4bn2021-04-01 → 2022-03-31dCons.Revenue IFRS (5-year summary)
Revenue¥309.3bn2020-04-01 → 2021-03-31dCons.Revenue IFRS (5-year summary)
Revenue¥292.4bn2019-04-01 → 2020-03-31dCons.Revenue IFRS (5-year summary)
Operating income¥159.9bn2023-04-01 → 2024-03-31Cons.Operating profit loss IFRS
Operating income¥142.0bn2022-04-01 → 2023-03-31Cons.Operating profit loss IFRS
Profit before tax¥163.7bn2023-04-01 → 2024-03-31Cons.Profit loss before tax IFRS
Profit before tax¥143.5bn2022-04-01 → 2023-03-31Cons.Profit loss before tax IFRS
Profit before tax¥105.0bn2021-04-01 → 2022-03-31dCons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥100.9bn2020-04-01 → 2021-03-31dCons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥79.7bn2019-04-01 → 2020-03-31dCons.Profit loss before tax IFRS (5-year summary)
Net income (owners)¥128.0bn2023-04-01 → 2024-03-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥112.7bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥80.5bn2021-04-01 → 2022-03-31dCons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥75.4bn2020-04-01 → 2021-03-31dCons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥59.7bn2019-04-01 → 2020-03-31dCons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income¥128.0bn2023-04-01 → 2024-03-31Cons.Profit loss IFRS
Net income¥112.9bn2022-04-01 → 2023-03-31Cons.Profit loss IFRS
Total assets¥913.7bnat 2024-03-31Cons.Assets IFRS
Total assets¥882.4bnat 2023-03-31Cons.Assets IFRS
Total assets¥739.2bnat 2022-03-31dCons.Total assets IFRS (5-year summary)
Total assets¥745.4bnat 2021-03-31dCons.Total assets IFRS (5-year summary)
Total assets¥673.4bnat 2020-03-31dCons.Total assets IFRS (5-year summary)
Total liabilities¥115.1bnat 2024-03-31Cons.Liabilities IFRS
Total liabilities¥134.6bnat 2023-03-31Cons.Liabilities IFRS
Net assets / equity¥798.6bnat 2024-03-31Cons.Equity IFRS
Net assets / equity¥747.8bnat 2023-03-31Cons.Equity IFRS
Net assets / equity¥661.7bnat 2022-03-31dCons.Equity IFRS
Equity (owners)¥793.0bnat 2024-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥741.9bnat 2023-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥655.9bnat 2022-03-31dCons.Equity attributable to owners of parent IFRS (5-year summary)
Equity (owners)¥634.1bnat 2021-03-31dCons.Equity attributable to owners of parent IFRS (5-year summary)
Equity (owners)¥562.5bnat 2020-03-31dCons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥166.1bnat 2024-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥96.1bnat 2023-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥69.1bnat 2022-03-31dCons.Cash and cash equivalents IFRS
Cash & equivalents¥61.0bnat 2021-03-31dCons.Cash and cash equivalents IFRS (5-year summary)
Cash & equivalents¥69.0bnat 2020-03-31dCons.Cash and cash equivalents IFRS (5-year summary)
Operating cash flow¥110.7bn2023-04-01 → 2024-03-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥159.6bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥61.8bn2021-04-01 → 2022-03-31dCons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥74.0bn2020-04-01 → 2021-03-31dCons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥74.2bn2019-04-01 → 2020-03-31dCons.Cash flows from used in operating activities IFRS (5-year summary)
Investing cash flow¥48.1bn2023-04-01 → 2024-03-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥100.3bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow¥6.0bn2021-04-01 → 2022-03-31dCons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥57.6bn2020-04-01 → 2021-03-31dCons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥10.2bn2019-04-01 → 2020-03-31dCons.Cash flows from used in investing activities IFRS (5-year summary)
Financing cash flow−¥89.8bn2023-04-01 → 2024-03-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥32.5bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥60.2bn2021-04-01 → 2022-03-31dCons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥24.8bn2020-04-01 → 2021-03-31dCons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥54.7bn2019-04-01 → 2020-03-31dCons.Cash flows from used in financing activities IFRS (5-year summary)
EPS (basic)¥266.612023-04-01 → 2024-03-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥230.852022-04-01 → 2023-03-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥162.192021-04-01 → 2022-03-31dCons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥151.112020-04-01 → 2021-03-31dCons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥118.472019-04-01 → 2020-03-31dCons.Basic earnings loss per share IFRS (5-year summary)
EPS (diluted)¥266.572023-04-01 → 2024-03-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥230.792022-04-01 → 2023-03-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥162.162021-04-01 → 2022-03-31dCons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥151.092020-04-01 → 2021-03-31dCons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥118.452019-04-01 → 2020-03-31dCons.Diluted earnings loss per share IFRS (5-year summary)
Net assets per share¥1,688.43at 2024-03-31Cons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥1,519.19at 2023-03-31Cons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥1,343.4at 2022-03-31dCons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥1,270.45at 2021-03-31dCons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥1,126.95at 2020-03-31dCons.Equity to asset ratio IFRS (5-year summary)
Equity ratio86.8%at 2024-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio84.1%at 2023-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio88.7%at 2022-03-31dCons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio85.1%at 2021-03-31dCons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio83.5%at 2020-03-31dCons.Ratio of owners equity to gross assets IFRS (5-year summary)
ROE16.7%2023-04-01 → 2024-03-31Cons.Rate of return on equity IFRS (5-year summary)
ROE16.1%2022-04-01 → 2023-03-31Cons.Rate of return on equity IFRS (5-year summary)
ROE12.5%2021-04-01 → 2022-03-31dCons.Rate of return on equity IFRS (5-year summary)
ROE12.6%2020-04-01 → 2021-03-31dCons.Rate of return on equity IFRS (5-year summary)
ROE10.7%2019-04-01 → 2020-03-31dCons.Rate of return on equity IFRS (5-year summary)
Employees3,853at 2024-03-31Cons.Number of employees
Employees3,761at 2023-03-31Cons.Number of employees
Employees3,687at 2022-03-31dCons.Number of employees
Employees3,607at 2021-03-31dCons.Number of employees
Employees3,560at 2020-03-31dCons.Number of employees
Revenue¥498.8bn2023-04-01 → 2024-03-31StandaloneNet sales
Revenue¥441.2bn2022-04-01 → 2023-03-31StandaloneNet sales
Revenue¥357.0bn2021-04-01 → 2022-03-31dStandaloneNet sales (5-year summary)
Revenue¥305.2bn2020-04-01 → 2021-03-31dStandaloneNet sales (5-year summary)
Revenue¥286.2bn2019-04-01 → 2020-03-31dStandaloneNet sales (5-year summary)
Operating income¥187.9bn2023-04-01 → 2024-03-31StandaloneOperating income
Operating income¥152.0bn2022-04-01 → 2023-03-31StandaloneOperating income
Ordinary income¥188.0bn2023-04-01 → 2024-03-31StandaloneOrdinary income
Ordinary income¥150.8bn2022-04-01 → 2023-03-31StandaloneOrdinary income
Ordinary income¥121.1bn2021-04-01 → 2022-03-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥86.8bn2020-04-01 → 2021-03-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥70.8bn2019-04-01 → 2020-03-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax¥198.0bn2023-04-01 → 2024-03-31StandaloneIncome before income taxes
Profit before tax¥148.2bn2022-04-01 → 2023-03-31StandaloneIncome before income taxes
Net income¥152.9bn2023-04-01 → 2024-03-31StandaloneProfit loss
Net income¥117.2bn2022-04-01 → 2023-03-31StandaloneProfit loss
Net income¥94.6bn2021-04-01 → 2022-03-31dStandaloneNet income loss (5-year summary)
Net income¥76.9bn2020-04-01 → 2021-03-31dStandaloneNet income loss (5-year summary)
Net income¥69.3bn2019-04-01 → 2020-03-31dStandaloneNet income loss (5-year summary)
Total assets¥847.3bnat 2024-03-31StandaloneAssets
Total assets¥804.6bnat 2023-03-31StandaloneAssets
Total assets¥661.9bnat 2022-03-31dStandaloneTotal assets (5-year summary)
Total assets¥669.6bnat 2021-03-31dStandaloneTotal assets (5-year summary)
Total assets¥599.4bnat 2020-03-31dStandaloneTotal assets (5-year summary)
Total liabilities¥97.1bnat 2024-03-31StandaloneLiabilities
Total liabilities¥119.0bnat 2023-03-31StandaloneLiabilities
Net assets / equity¥750.2bnat 2024-03-31StandaloneNet assets
Net assets / equity¥685.6bnat 2023-03-31StandaloneNet assets
Net assets / equity¥599.2bnat 2022-03-31dStandaloneNet assets
Net assets / equity¥574.6bnat 2021-03-31dStandaloneNet assets (5-year summary)
Net assets / equity¥507.7bnat 2020-03-31dStandaloneNet assets (5-year summary)
Cash and deposits¥184.8bnat 2024-03-31StandaloneCash and deposits
Cash and deposits¥147.0bnat 2023-03-31StandaloneCash and deposits
EPS (basic)¥318.512023-04-01 → 2024-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥239.962022-04-01 → 2023-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥190.512021-04-01 → 2022-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥154.12020-04-01 → 2021-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥137.592019-04-01 → 2020-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥318.492023-04-01 → 2024-03-31StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥239.942022-04-01 → 2023-03-31StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥190.492021-04-01 → 2022-03-31dStandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥154.082020-04-01 → 2021-03-31dStandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥137.572019-04-01 → 2020-03-31dStandaloneDiluted earnings per share (5-year summary)
Dividend per share¥802023-04-01 → 2024-03-31StandaloneDividend paid per share (5-year summary)
Dividend per share¥702022-04-01 → 2023-03-31StandaloneDividend paid per share (5-year summary)
Dividend per share¥562021-04-01 → 2022-03-31dStandaloneDividend paid per share (5-year summary)
Dividend per share¥502020-04-01 → 2021-03-31dStandaloneDividend paid per share (5-year summary)
Dividend per share¥452019-04-01 → 2020-03-31dStandaloneDividend paid per share (5-year summary)
Net assets per share¥1,597.16at 2024-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥1,403.84at 2023-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥1,226.79at 2022-03-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥1,150.68at 2021-03-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥1,016.83at 2020-03-31dStandaloneNet assets per share (5-year summary)
Equity ratio88.5%at 2024-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio85.2%at 2023-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio90.5%at 2022-03-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio85.8%at 2021-03-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio84.7%at 2020-03-31dStandaloneEquity to asset ratio (5-year summary)
ROE21.3%2023-04-01 → 2024-03-31StandaloneRate of return on equity (5-year summary)
ROE18.2%2022-04-01 → 2023-03-31StandaloneRate of return on equity (5-year summary)
ROE16.1%2021-04-01 → 2022-03-31dStandaloneRate of return on equity (5-year summary)
ROE14.2%2020-04-01 → 2021-03-31dStandaloneRate of return on equity (5-year summary)
ROE13.7%2019-04-01 → 2020-03-31dStandaloneRate of return on equity (5-year summary)
Shares issued498,692,000at 2024-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued517,425,000at 2023-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued528,341,000at 2022-03-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued528,341,000at 2021-03-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued528,341,000at 2020-03-31dStandaloneTotal number of issued shares (5-year summary)
Employees3,437at 2024-03-31StandaloneNumber of employees
Employees3,381at 2023-03-31StandaloneNumber of employees
Employees3,354at 2022-03-31dStandaloneNumber of employees
Employees3,319at 2021-03-31dStandaloneNumber of employees
Employees3,287at 2020-03-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 2
SegmentItemPeriodValue
Pharmaceutical Productsreportable segmentemployeesat 2024-03-313853 pure
Pharmaceutical Productsreportable segmentemployeesat 2024-03-313437 pure

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 1,933
ItemContextValueUnit
Address major shareholdersCurrentYearInstant_No3MajorShareholdersMember
Original text (Japanese)東京都千代田区丸の内２丁目１番１号(東京都中央区晴海１丁目８番12号)
Name major shareholdersCurrentYearInstant_No4MajorShareholdersMember
Original text (Japanese)公益財団法人小野奨学会
Address major shareholdersCurrentYearInstant_No4MajorShareholdersMember
Original text (Japanese)大阪府大阪市中央区平野町２丁目６番11号　ホーコス伏見屋ビル301号室
Name major shareholdersCurrentYearInstant_No5MajorShareholdersMember
Original text (Japanese)株式会社鶴鳴荘
Address major shareholdersCurrentYearInstant_No5MajorShareholdersMember
Original text (Japanese)兵庫県芦屋市松ノ内町３番８-３号CRANE BLDG. ASHIYA２F
Name major shareholdersCurrentYearInstant_No6MajorShareholdersMember
Original text (Japanese)ステート　ストリート　バンク　ウェスト　クライアント トリーティー　505234（常任代理人株式会社みずほ銀行）
Address major shareholdersCurrentYearInstant_No6MajorShareholdersMemberText · Plus
Name major shareholdersCurrentYearInstant_No7MajorShareholdersMember
Original text (Japanese)株式会社三菱ＵＦＪ銀行
Address major shareholdersCurrentYearInstant_No7MajorShareholdersMember
Original text (Japanese)東京都千代田区丸の内２丁目７番１号
Name major shareholdersCurrentYearInstant_No8MajorShareholdersMember
Original text (Japanese)あいおいニッセイ同和損害保険株式会社(常任代理人日本マスタートラスト信託銀行株式会社)
Address major shareholdersCurrentYearInstant_No8MajorShareholdersMember
Original text (Japanese)東京都渋谷区恵比寿１丁目28番１号(東京都港区赤坂１丁目８番１号赤坂インターシティAIR)
Name major shareholdersCurrentYearInstant_No9MajorShareholdersMember
Original text (Japanese)SSBTC CLIENT OMNIBUS ACCOUNT（常任代理人香港上海銀行）
Address major shareholdersCurrentYearInstant_No9MajorShareholdersMemberText · Plus
Name major shareholdersCurrentYearInstant_No10MajorShareholdersMember
Original text (Japanese)ジェーピー　モルガン　チェース　バンク　385781（常任代理人株式会社みずほ銀行）
Address major shareholdersCurrentYearInstant_No10MajorShareholdersMemberText · Plus
Issued shares voting rights (text)FilingDateInstantText · Plus
Description issued shares voting rightsCurrentYearInstant_SharesWithNoVotingRightsMember－
Description issued shares voting rightsCurrentYearInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember－
Description issued shares voting rightsCurrentYearInstant_SharesWithRestrictedVotingRightsOtherMember－
Description issued shares voting rightsCurrentYearInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember－
Description issued shares voting rightsCurrentYearInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember－
Description issued shares voting rightsCurrentYearInstant_OrdinarySharesSharesLessThanOneUnitMember
Original text (Japanese)１単元(100株)未満の株式
Treasury shares etc (text)FilingDateInstantText · Plus
Name of shareholder treasury shares etcCurrentYearInstant_Row1Member
Original text (Japanese)小野薬品工業株式会社
Address of shareholder treasury shares etcCurrentYearInstant_Row1Member
Original text (Japanese)大阪市中央区道修町二丁目１番５号
Classes of shares etc (text)FilingDateInstantText · Plus
Acquisitions by resolution of shareholders meeting (text)FilingDateInstantText · Plus
Acquisitions by resolution of board of directors meeting (text)FilingDateInstantText · Plus
Acquisitions not based on resolution of shareholders meeting or board of directors meeting (text)FilingDateInstantText · Plus
Disposals or holding of acquired treasury shares (text)FilingDateInstantText · Plus
Dividend policy (text)FilingDateInstantText · Plus
Date of resolution dividends of surplusFilingDateInstant_Row1Member2023-11-01
Resolution dividends of surplusFilingDateInstant_Row1Member
Original text (Japanese)取締役会決議
Date of resolution dividends of surplusFilingDateInstant_Row2Member2024-06-20
Resolution dividends of surplusFilingDateInstant_Row2Member
Original text (Japanese)定時株主総会決議
Overview of corporate governance (text)FilingDateInstantText · Plus
Corporate governance company with corporate auditors (text)FilingDateInstantText · Plus
Information about officers (text)FilingDateInstantText · Plus
Official title or position information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E00945-000SagaraGyoMember
Original text (Japanese)代表取締役取締役会長CEO
Name information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E00945-000SagaraGyoMember
Original text (Japanese)相　良　　　暁
Date of birth information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E00945-000SagaraGyoMember1958-10-07
Career summary information about directors and corporate auditors (text)FilingDateInstant_jpcrp030000-asr_E00945-000SagaraGyoMemberText · Plus
Term of office information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E00945-000SagaraGyoMember
Original text (Japanese)(注)3
Official title or position information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E00945-000TakinoToichiMember
Original text (Japanese)代表取締役取締役社長COO
Name information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E00945-000TakinoToichiMember
Original text (Japanese)滝　野　十　一
Date of birth information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E00945-000TakinoToichiMember1968-01-14
Career summary information about directors and corporate auditors (text)FilingDateInstant_jpcrp030000-asr_E00945-000TakinoToichiMemberText · Plus
Term of office information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E00945-000TakinoToichiMember
Original text (Japanese)(注)3
Official title or position information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E00945-000TsujinakaToshihiroMember
Original text (Japanese)代表取締役副社長執行役員経営戦略本部長兼ビジネスデザイン部長兼サステナビリティ推進部長
Name information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E00945-000TsujinakaToshihiroMember
Original text (Japanese)辻　中　聡　浩

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 21 of 21 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2024-03-31pass rounding
balance sheet identitynon_consolidated 2023-03-31pass
balance sheet identitynon_consolidated 2024-03-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2022-03-31pass
statement vs summary · net assetsnon_consolidated 2023-03-31pass
statement vs summary · net assetsnon_consolidated 2024-03-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2023-03-31pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2024-03-31pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2023-03-31pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2024-03-31pass
statement vs summary · revenueconsolidated 2022-04-01/2023-03-31pass
statement vs summary · revenueconsolidated 2023-04-01/2024-03-31pass
statement vs summary · revenuenon_consolidated 2022-04-01/2023-03-31pass
statement vs summary · revenuenon_consolidated 2023-04-01/2024-03-31pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2024-03-31pass
statement vs summary · total assetsnon_consolidated 2023-03-31pass
statement vs summary · total assetsnon_consolidated 2024-03-31pass